{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:38:45Z","timestamp":1767836325478,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YC1000700"],"award-info":[{"award-number":["2016YC1000700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.seizure.2022.05.010","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T18:53:01Z","timestamp":1652727181000},"page":"71-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin"],"prefix":"10.1016","volume":"99","author":[{"given":"Qian","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Dun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-9378","authenticated-orcid":false,"given":"Li-Ping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2022.05.010_bib0001","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jiph.2020.10.008","article-title":"COVID-19 infection prevalence in pediatric population: etiology, clinical presentation, and outcome","volume":"13","author":"Alsohime","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.seizure.2022.05.010_bib0002","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S1473-3099(21)00319-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1\/2 clinical trial","volume":"21","author":"Han","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.seizure.2022.05.010_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.seizure.2022.05.010_bib0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","article-title":"A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.seizure.2022.05.010_bib0005","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.seizure.2022.05.010_bib0006","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-021-22166-4","article-title":"SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition","volume":"12","author":"Mullen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.seizure.2022.05.010_bib0007","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.seizure.2021.06.035","article-title":"Stick or twist: everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic","volume":"91","author":"Moloney","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2022.05.010_bib0008","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2022.05.010_bib0009","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.05.010_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/epi.17138","article-title":"COVID-19 vaccine take-up rate and safety in adults with epilepsy: data from a multicenter study in China","volume":"63","author":"Lu","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.05.010_bib0011","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8\u207a T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.seizure.2022.05.010_bib0012","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/scitranslmed.aaq1564","article-title":"TORC1 inhibition enhances immune function and reduces infections in the elderly","volume":"10","author":"Mannick","year":"2018","journal-title":"Sci Transl Med"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:01:19Z","timestamp":1761012079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":12,"alternative-id":["S1059131122001145"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.05.010","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}